Abstract:Neurotransmitter transporters play a major role in achieving low concentrations of their respective transmitter in the synaptic cleft. The GABA transporter GAT1 belongs to the family of Na+‐ and Cl–‐coupled transport proteins which possess 12 putative transmembrane domains and three N‐glycosylation sites in the extracellular loop between transmembrane domain 3 and 4. To study the significance of N‐glycosylation, green fluorescence protein (GFP)‐tagged wild type GAT1 (NNN) and N‐glycosylation defective mutants (DDQ, DGN, DDN and DDG) were expressed in CHO cells. Compared with the wild type, all N‐glycosylation mutants showed strongly reduced protein stability and trafficking to the plasma membrane, which however were not affected by 1‐deoxymannojirimycin (dMM). This indicates that N‐glycosylation, but not terminal trimming of the N‐glycans is involved in the attainment of a correctly folded and stable conformation of GAT1. All N‐glycosylation mutants were expressed on the plasma membrane, but they displayed markedly reduced GABA‐uptake activity. Also, inhibition of oligosaccharide processing by dMM led to reduction of this activity. Further experiments showed that both N‐glycosylation mutations and dMM reduced the Vmax value, while not increasing the Km value for GABA uptake. Electrical measurements revealed that the reduced transport activity can be partially attributed to a reduced apparent affinity for extracellular Na+ and slowed kinetics of the transport cycle. This indicates that N‐glycans, in particular their terminal trimming, are important for the GABA‐uptake activity of GAT1. They play a regulatory role in the GABA translocation by affecting the affinity and the reaction steps associated with the sodium ion binding.

Regulated N-glycosylation controls chaperone function and receptor trafficking

Substrate-directed control of N-glycosylation in the endoplasmic reticulum calibrates signal reception at the cell-surface

O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling

O-GlcNAcylation of Core Components of the Translation Initiation Machinery Regulates Protein Synthesis.

N-glycosylation of the human neuropeptide QRFP receptor (QRFPR) is essential for ligand binding and receptor activation

Proteome and Glycoproteome Analyses Reveal Regulation of Protein Glycosylation Site-Specific Occupancy and Lysosomal Hydrolase Maturation by N-Glycan-Dependent ER-Quality Control

N-Glycosylation as a Modulator of Protein Conformation and Assembly in Disease

Oligosaccharyltransferase is involved in targeting to ER-associated degradation

Molecular Stressors Engender Protein Connectivity Dysfunction through Aberrant N-Glycosylation of a Chaperone

The Role of N‐glycosylation in the Stability, Trafficking and GABA‐uptake of GABA‐transporter 1

N-glycosylation of α1D-adrenergic receptor N-terminal domain is required for correct trafficking, function, and biogenesis

Protein Glycosylation Patterns Shaped By the IRE1‐XBP1s Arm of the Unfolded Protein Response

Oxidoreductases in Glycoprotein Glycosylation, Folding, and ERAD

Regulation of Glycosylation in Bone Metabolism

Importance of N-Glycosylation for the Expression and Function of Human Organic Anion Transporting Polypeptide 2B1

Site-to-site cross-talk in OST-B glycosylation of hCEACAM1-IgV

Polypeptide N-acetylgalactosaminyltransferase 18 non-catalytically regulates the ER homeostasis and O-glycosylation

UGGT1-mediated reglucosylation of N-glycan competes with ER-associated degradation of unstable and misfolded glycoproteins

Acceptors stability modulates the efficiency of post-translational protein N-glycosylation

Substrate O-glycosylation actively regulates extracellular proteolysis

N‐Glycosylation‐induced pathologic protein conformations as a tool to guide the selection of biologically active small molecules